

Everything you need to know about Ciclesonide (Alvesco, Omnaris): what it treats, how to take it, dosing, side effects, and key facts for 2026.
Ciclesonide is a prescription inhaled corticosteroid (also called a glucocorticoid) used to treat persistent asthma and allergic rhinitis (seasonal and year-round allergies). It works by reducing inflammation in your airways and nasal passages, helping you breathe easier and reducing allergy symptoms like congestion, sneezing, and runny nose.
Ciclesonide is available under three brand names:
Ciclesonide is manufactured by Covis Pharma. There is currently no generic version available in the United States.
Ciclesonide is FDA-approved for the following conditions:
Alvesco is used as a daily maintenance treatment for persistent asthma in patients aged 12 and older. It is not a rescue inhaler — it won't help during an asthma attack. Instead, it works over time to reduce the inflammation that causes asthma symptoms like wheezing, shortness of breath, and chest tightness.
Omnaris nasal spray is approved for seasonal allergic rhinitis in patients aged 6 and older. Zetonna nasal aerosol is approved for patients aged 12 and older. These treat symptoms like nasal congestion, sneezing, runny nose, and itchy nose caused by seasonal allergies (hay fever).
Omnaris is also approved for year-round (perennial) allergic rhinitis in patients aged 12 and older. This covers allergies to things like dust mites, pet dander, and mold that persist throughout the year.
Ciclesonide has a unique feature: it's a prodrug. This means the medication you inhale is not yet active. It gets converted to its active form (called des-Ciclesonide) only after it reaches your lungs or nasal passages. This targeted activation has some advantages:
To learn more about how this works at a molecular level, read our guide on how Ciclesonide works.
The biggest drug interaction concern with Ciclesonide is strong CYP3A4 inhibitors like Ketoconazole, which can significantly increase Ciclesonide levels in your body. For the full list, see our guide on Ciclesonide drug interactions.
Most side effects are mild:
For a complete breakdown of what to watch for, including serious side effects, read our detailed guide on Ciclesonide side effects.
Because there's no generic, Ciclesonide can be expensive:
Insurance covers Alvesco in about 77% of plans, with typical copays of $15 to $75. Some plans may require prior authorization or step therapy (trying a cheaper medication first).
There are ways to save. The Alvesco Savings Card from Covis Pharma can bring your cost down to $0 if you have commercial insurance. There's also a patient assistance program for uninsured patients. Read our full guide on how to save money on Ciclesonide.
Ciclesonide is not currently on the FDA drug shortage list, but because it's a single-source brand product, not all pharmacies stock it. If your pharmacy doesn't have it, they can usually order it in 1-2 days. You can also use MedFinder to check which pharmacies have Ciclesonide in stock near you.
If you're wondering how Ciclesonide compares to other options, here's a quick look:
Ciclesonide's main advantages are its prodrug design (fewer local side effects) and once-daily dosing convenience. Learn more in our alternatives guide.
Ciclesonide is a well-established inhaled corticosteroid used for asthma and allergic rhinitis. Its prodrug design sets it apart by reducing common side effects like oral thrush and hoarseness. While it's only available as a brand-name product and can be pricey, savings programs exist to help. If your doctor has prescribed Ciclesonide, MedFinder can help you find it in stock at a pharmacy near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.